Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.68
$0.022.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.86M | 6.38M | 6.70M | 4.66M | 4.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.92M | 10.91M | 11.69M | 9.26M | 7.70M |
| Operating Income | -11.92M | -10.91M | -11.69M | -9.26M | -7.70M |
| Income Before Tax | -11.72M | -10.71M | -12.14M | -10.47M | -9.14M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.72 | -10.71 | -12.14 | -10.47 | -9.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.72M | -10.71M | -12.14M | -10.47M | -9.14M |
| EBIT | -11.92M | -10.91M | -11.69M | -9.26M | -7.70M |
| EBITDA | -11.63M | -10.90M | -11.69M | -9.26M | -7.69M |
| EPS Basic | -12.88 | -20.06 | -58.84 | -79.67 | -92.92 |
| Normalized Basic EPS | -8.13 | -12.53 | -31.85 | -44.95 | -52.73 |
| EPS Diluted | -12.88 | -21.92 | -60.70 | -81.54 | -94.79 |
| Normalized Diluted EPS | -8.13 | -12.53 | -31.85 | -44.95 | -52.73 |
| Average Basic Shares Outstanding | 6.53M | 3.96M | 1.82M | 778.10K | 459.10K |
| Average Diluted Shares Outstanding | 6.53M | 3.96M | 1.82M | 778.10K | 459.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |